{"corpus_id":28659266,"paper_sha":"f48a9fbf64bbe70a5a78a0fba575f7c6bef2fa4f","doi":"10.3748/WJG.14.5695","arxiv_id":null,"pmid":18837086,"pmcid":"PMC2748204","mag_id":1505375435,"dblp_id":null,"acl_id":null,"title":"Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.","year":2008,"publication_date":"2008-10-07","venue":"World Journal of Gastroenterology","journal":{"name":"World journal of gastroenterology","pages":"\n          5695-700\n        ","volume":"14 37"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article"],"s2_fields_of_study":["Medicine"],"reference_count":45,"citation_count":73,"influential_citation_count":0,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Aged","mj":false,"ui":"D000368"},{"d":"Carcinoma, Hepatocellular","mj":false,"qs":[{"q":"epidemiology","mj":false,"ui":"Q000453"},{"q":"etiology","mj":true,"ui":"Q000209"}],"ui":"D006528"},{"d":"Case-Control Studies","mj":false,"ui":"D016022"},{"d":"Diabetes Mellitus, Type 2","mj":false,"qs":[{"q":"complications","mj":true,"ui":"Q000150"},{"q":"drug therapy","mj":false,"ui":"Q000188"},{"q":"epidemiology","mj":false,"ui":"Q000453"}],"ui":"D003924"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Hypoglycemic Agents","mj":false,"qs":[{"q":"adverse effects","mj":false,"ui":"Q000009"},{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D007004"},{"d":"Insulin","mj":false,"qs":[{"q":"adverse effects","mj":false,"ui":"Q000009"},{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D007328"},{"d":"Italy","mj":false,"qs":[{"q":"epidemiology","mj":false,"ui":"Q000453"}],"ui":"D007558"},{"d":"Liver Neoplasms","mj":false,"qs":[{"q":"epidemiology","mj":false,"ui":"Q000453"},{"q":"etiology","mj":true,"ui":"Q000209"}],"ui":"D008113"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Metformin","mj":false,"qs":[{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D008687"},{"d":"Middle Aged","mj":false,"ui":"D008875"},{"d":"Odds Ratio","mj":false,"ui":"D016017"},{"d":"Prevalence","mj":false,"ui":"D015995"},{"d":"Risk Assessment","mj":false,"ui":"D018570"},{"d":"Risk Factors","mj":false,"ui":"D012307"},{"d":"Sex Factors","mj":false,"ui":"D012737"},{"d":"Sulfonylurea Compounds","mj":false,"qs":[{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D013453"},{"d":"Time Factors","mj":false,"ui":"D013997"}],"chemicals":[{"n":"Hypoglycemic Agents","ui":"D007004","reg":"0"},{"n":"Insulin","ui":"D007328","reg":"0"},{"n":"Sulfonylurea Compounds","ui":"D013453","reg":"0"},{"n":"Metformin","ui":"D008687","reg":"9100L32L2N"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"AIM\nTo investigate the relationships between Type 2 diabetes mellitus (DM2) and the risk of hepatocellular carcinoma (HCC).\n\n\nMETHODS\nWe studied the association between DM2 and HCC in a large case-control study that enrolled 465 consecutive Caucasian patients with HCC (78.3% males, mean age 68.5 +/- 8.9 years) compared with an age and sex matched control group of 490 subjects.\n\n\nRESULTS\nPrevalence of DM2 was significantly higher in HCC patients (31.2% vs 12.7%; OR = 3.12, 95% CI: 2.22-4.43) and in HCC cases with alcohol abuse. DM2 has been diagnosed before the appearance of HCC in 84.1% of diabetic HCC subjects with mean duration of 141.5 mo, higher in cases treated with insulin than in those with oral antidiabetic agents (171.5 vs 118.7 mo). Compared to controls, males DM2 with HCC were more frequently treated with insulin (38.1% vs 17.6%, P = 0.009) and with sulfonylurea with or without metformin than with diet with or without metformin (84% vs 68.3%, P = 0.049).\n\n\nCONCLUSION\nDM2 in our patients is associated with a 3-fold increase risk of HCC. In most of our cases DM2 pre-existed to HCC. Patients with DM2 and chronic liver disease, particularly insulin treated males, should be considered for HCC close surveillance programs.","claims":[{"public_id":"cl_9392efb1b41fe8f708d9d60eefec7134","status":"active","text":"Male diabetic HCC patients were more frequently treated with insulin than controls (38.1% vs 17.6%, P = 0.009) and more frequently treated with sulfonylurea with or without metformin rather than diet with or without metformin (84% vs 68.3%, P = 0.049).","confidence":0.85,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_9392efb1b41fe8f708d9d60eefec7134"},{"public_id":"cl_61647a485f0b10e05a6421eea7de99e3","status":"active","text":"Type 2 diabetes mellitus is associated with a 3-fold increased risk of hepatocellular carcinoma, with prevalence significantly higher in HCC patients than in matched controls (31.2% vs 12.7%; OR = 3.12, 95% CI: 2.22-4.43).","confidence":0.92,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_61647a485f0b10e05a6421eea7de99e3"},{"public_id":"cl_06f3531fc423daae3f4c6e98cedf50f5","status":"active","text":"Type 2 diabetes mellitus was diagnosed before the appearance of hepatocellular carcinoma in 84.1% of diabetic HCC patients, with a longer mean diabetes duration in those treated with insulin than in those treated with oral antidiabetic agents (171.5 vs 118.7 months).","confidence":0.85,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_06f3531fc423daae3f4c6e98cedf50f5"}],"concepts":[{"public_id":"co_096b3bf19cb0cf1f22f154ef220e6196","status":"active","name":"case-control study","description":"A study design comparing patients with hepatocellular carcinoma to age- and sex-matched controls to assess prior exposure differences such as diabetes.","types":["study design"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_096b3bf19cb0cf1f22f154ef220e6196"},{"public_id":"co_320eee4cacf3234d1d0f85f35c2cbe10","status":"active","name":"insulin","description":"An injectable antidiabetic hormone used to manage type 2 diabetes mellitus, examined here as a treatment used by diabetic HCC patients.","types":["treatment","drug"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_320eee4cacf3234d1d0f85f35c2cbe10"},{"public_id":"co_729c21c9447884129ecc8569fc941732","status":"active","name":"type 2 diabetes mellitus","description":"A metabolic disease characterized by insulin resistance and hyperglycemia, examined here as a potential risk factor for hepatocellular carcinoma.","types":["condition"],"aliases":["DM2"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_729c21c9447884129ecc8569fc941732"},{"public_id":"co_9be49a36f966e93b4b2cd26030a21a4c","status":"active","name":"hepatocellular carcinoma","description":"A primary liver cancer that is the disease outcome studied in relation to diabetes status in this case-control study.","types":["condition"],"aliases":["HCC"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_9be49a36f966e93b4b2cd26030a21a4c"},{"public_id":"co_a0cc205f2d6bb2b385853bf2b5d1b3ee","status":"active","name":"alcohol abuse","description":"Excessive alcohol consumption considered here as a factor associated with hepatocellular carcinoma cases having type 2 diabetes mellitus.","types":["risk factor"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_a0cc205f2d6bb2b385853bf2b5d1b3ee"},{"public_id":"co_e0ed0320f91803da9aeb2ebc79ddbd9a","status":"active","name":"oral antidiabetic agents","description":"Oral medications used to manage type 2 diabetes mellitus, compared here with insulin as a diabetes treatment.","types":["treatment","drug class"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_e0ed0320f91803da9aeb2ebc79ddbd9a"},{"public_id":"co_e1de07b4009f7b65b6c99f55c49548f9","status":"active","name":"metformin","description":"An oral antidiabetic drug used alone or in combination with other agents to manage type 2 diabetes mellitus.","types":["drug"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_e1de07b4009f7b65b6c99f55c49548f9"},{"public_id":"co_e883c640eab6acbd3f9c9172067a6815","status":"active","name":"odds ratio","description":"A statistical measure of association used here to quantify the relative risk of hepatocellular carcinoma associated with type 2 diabetes mellitus.","types":["statistical measure"],"aliases":["OR"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_e883c640eab6acbd3f9c9172067a6815"},{"public_id":"co_ee802277e3e20b51ea2a5fe65672816c","status":"active","name":"sulfonylurea","description":"A class of oral antidiabetic drugs that stimulate insulin secretion, considered here as a diabetes treatment.","types":["drug"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_ee802277e3e20b51ea2a5fe65672816c"},{"public_id":"co_f7777352887970e300be4b4cf5257728","status":"active","name":"chronic liver disease","description":"Long-standing liver disease identified as a condition in patients recommended for hepatocellular carcinoma surveillance in this study.","types":["condition"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_f7777352887970e300be4b4cf5257728"}],"external_ids":{"DOI":"10.3748/WJG.14.5695","ArXiv":null,"PubMed":18837086,"PubMedCentral":"PMC2748204","MAG":1505375435,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/28659266","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631201,"paper_uid":"0dea1f30-043f-44be-bb41-dd8080b7bbd1","canonical_identity":{"paper_id":631201,"paper_uid":"0dea1f30-043f-44be-bb41-dd8080b7bbd1","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/28659266"}